Page last updated: 2024-08-17

adenosine monophosphate and Local Neoplasm Recurrence

adenosine monophosphate has been researched along with Local Neoplasm Recurrence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bai, X; Castellanos, E; Davies, J; Fisher, V; Gower-Page, C; Mhatre, SK; Patel, A; Price, R; Reyes-Rivera, I; Schröder, C; Sen, S; Snider, J1
Gadzińska, J; Kloc, M; Kubiak, JZ; Kuchar, E; Matysiak, M; Wanke-Rytt, M1

Other Studies

2 other study(ies) available for adenosine monophosphate and Local Neoplasm Recurrence

ArticleYear
Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice.
    JCO clinical cancer informatics, 2022, Volume: 6

    Topics: Adenosine Monophosphate; Colonic Neoplasms; Colorectal Neoplasms; Humans; Neoplasm Recurrence, Local; Receptor, ErbB-2; Retrospective Studies

2022
A 10-Year-old Girl With Late Acute Lymphoblastic Leukemia Recurrence Diagnosed With COVID-19 and Treated With Remdesivir.
    Journal of pediatric hematology/oncology, 2022, 03-01, Volume: 44, Issue:2

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Child; COVID-19; COVID-19 Drug Treatment; Female; Humans; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; SARS-CoV-2

2022